Medscape at ASH 2025: Landmark Value Through the Medscape AI Debut and Five Educational Symposia
December 1, 2025 |
For decades, Medscape has been the brand physicians trust. Now, Medscape is forging a new path into the future at ASH 2025 with the launch of Medscape AI — the first and only medical-grade Generative AI experience that integrates Medscape’s proprietary content, peer-reviewed literature, and real-time medical news to deliver timely, trustworthy, specialty-specific insights that support informed decision-making.
Medscape AI marks a transformation from a single search tool to a robust platform of integrated AI-powered solutions for HCPs. This shift emphasizes integration, bringing together multiple AI capabilities designed to support clinicians in all aspects of their practice, beyond just search, making the evolution substantial and future-oriented with exciting developments to come.
Among the proven benefits of Medscape AI:
- Reliability: Clinically Vetted Sources, Transparent By Design
- Built on both Medscape’s trusted proprietary content and evidence from 400+ of the most prestigious peer-reviewed journals across a wide range of specialties — spanning oncology, cardiology, dermatology, internal medicine, and beyond — with no unverified material from the open internet
- AI responses are traceable, transparent, and supported by citations
- Recency: Always Current and Continuously Updated
- Integrates verified real-time news, research updates, and guideline changes
- Daily and weekly editorial oversight ensures outputs reflect the latest evidence
- Relevance: Aligned to Practice and Patient Care
- Jointly built with practicing clinicians to bridge the gap between AI innovations and clinical reality
- Synthesized insights tuned to each specialty, workflow, and clinical context
- Guidance supports differential diagnosis, treatment decisions, and next-step care
- Integrated across the Medscape experience, including the industry-leading Medscape newsreader and point-of-care decision support tools
- Time-Saving Clinical Efficiency
- Digestible, actionable responses free up clinicians to focus more on patient care and less time searching and reviewing literature
“As AI becomes essential to modern clinical practice, it not only needs to unlock unmatched value to our users, it must also meet the rigorous standards clinicians require: accurate, current, and evidence-based,” said Bob Brisco, CEO of Medscape’s parent company, Internet Brands. “Medscape AI delivers this and more. It cuts through the information overload plaguing healthcare professionals, synthesizing evidence instantly to drive better patient outcomes. It’s clinical precision in your pocket – expert guidance that’s tailored to meet your exact query, grounded in evidence, and powered by Medscape’s human-validated compendium of medical expertise.”
Medscape is advancing medical education through data-driven insights and innovative technology . Focused on the oncology and hematology community at ASH 2025, Medscape Education delivers transformative CME solutions that go beyond knowledge transfer to impact real-world clinical behavior, and, most critically, patient outcomes. Between 2023 and 2025 Medscape’s learning design and scientific content teams have delivered 102 programs in hematology, reaching 836,531 learners, who are potentially impacting over 3 million patients per month.
Visit booth #443 to explore our comprehensive hematology education offerings and get hands-on experience with the new Medscape AI feature!
Educational Symposia
Join us on Friday, December 5, 2025 for 5 Medscape Oncology educational symposia designed to help clinicians translate the latest clinical data into practice. Register here.
- Rare Clinical Spotlight: Exploring Castleman Disease, Cold Agglutinin Disease and Acute Intermittent Porphyria
- Time: 11:30 AM – 1:00 PM ET
- Hyatt Regency Orlando, 9801 International Drive, Orlando, Florida, 32819
- Room: Plaza International HIJK
- Targeted Therapies in R/R PCNSL: New Frontiers in Treatment and Management
- Time: 11:30 AM – 1:00 PM ET
- Hyatt Regency Orlando, 9801 International Drive, Orlando, Florida, 32819
- Room: Plaza International DEFG
- Tailoring Bispecific Antibodies to Individualize R/R Follicular Lymphoma Care: A Case-Based Discussion
- Time: 11:30 AM – 1:00 PM ET
- Orange County Convention Center, 9800 International Drive, Orlando, FL, 32819
- Room: W311 EFGH
- Personalizing Relapsed/Refractory DLBCL With Bispecific Antibody Therapy: A Case-Based Discussion
- Time: 3:30 PM – 5:00 PM ET
- Orange County Convention Center, 9800 International Drive, Orlando, FL, 32819
- Room: W311 EFGH
- Acute Hepatic Porphyria: Bridging Gaps for Better Diagnosis and Management
- Time: 3:30 PM – 5:00 PM ET
- Hyatt Regency Orlando, 9801 International Drive, Orlando, Florida, 32819
- Room: Plaza International HIJK
ASH Abstract Publication
Michelle Worst, PharmD, BCOP, MBA, CHCP has an online abstract accepted at ASH 2025. The abstract, titled “Assessing the influence of live and online enduring CME activities presented at the 66th ASH annual meeting on hematology/oncology specialists using pre-/post-education evaluations,” will be published online-only on the ASH abstracts site in the November supplemental issue of Blood.
For more information, please contact Jelena Spyropoulos.
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
Medscape Education and M4RD: Together Caring for Rare Disease
We are excited to finally share our news-style video ' ', developed in partnership with Medics 4 Rare Diseases (M4RD) and produced by Genetic Alliance UK and ITN Business.For more information on...
The Need for and Impact of Rare Disease Education
Physicians are often told that when they hear hoofbeats, think horses, not zebras — to look for the most common cause of a patient’s symptoms first. While this advice may...
Medscape Education: Rare Diseases Fibrodysplasia Ossificans Progressiva
Rare Disease Day is on February 28.Listen to Nicky explain her daughter's journey with fibrodysplasia ossificans progressiva.Many patients face long waits for accurate diagnosis and treatment, making it critically important...
Medscape Education: Rare Diseases
It's only a few days until #RareDiseaseDay2023 on 28th February. We're taking a patient centered approach, this means understanding their journey so we can better understand how we can help to...
Together Caring for Rare Disease
Medscape Education and Medics4RareDisease are partnering on a Rare Disease Day awareness campaign. The campaign will form part of a series of short programs produced by ITN in collaboration with Genetic Alliance...
Medscape Education Wins Best Practice Award for Learner Outcomes at NAMEC
This year's winners have been announced for the National Association of Medical Education Companies (NAMEC) awards. These awards recognize best practices-ideas or processes that can be implemented by NAMEC members to...
Medscape Education and Medics4RareDisease Uncover the Education Gaps in Their Compelling Rare Disease Day Campaign
Medscape Education and Medics4RareDisease are partnering on a Rare Disease Day awareness campaign. The campaign will form part of a series of short programs produced by ITN in collaboration with Genetic Alliance...
What Does Net Promoter Score Offer in the Evaluation of Continuing Medical Education?
Net promoter Score (NPS) has been used in many fields, such as software, clinical care, and websites, as a measure of customer satisfaction since 2003. With a single question, NPS...
DIGITAL HEALTH IN PRACTICE AND OVERCOMING DIGITAL FATIGUE
During this year’s Reuters event, Pharma 2022, WebMD CMO, Dr John Whyte discussed the ways in which digital health is growing, and the importance of educating clinicians in the right...
ESMO’s New Focus on Cancer Prevention
During ESMO 2022 in Paris, John Whyte, chief medical officer at WebMD was joined by Fabrice André, MD, PhD, Chair of the scientific committee at the European Society for Medical Oncology (ESMO),...